[1]
Almeida, A.T.C. de et al. 2019. Impacts of a Brazilian pharmaceutical program on the health of chronic patients. Revista de Saúde Pública. 53, (Jan. 2019), 20. DOI:https://doi.org/10.11606/S1518-8787.2019053000733.